Combating Counterfeit and Falsified Medical Products 
G8 Leaders take note of the grave threat that counterfeit and falsified medical products pose to public health. Increased access to the Internet, coupled with new methods of manufacturing and distributing counterfeit, falsified medical products have created new challenges to safeguarding the legitimate supply chain. Given these transactions chains often cross national borders, G-8 Leaders encourage increased cross-border cooperation to effectively combat this problem. Combating counterfeit and falsified drugs in this context does not aim to jeopardize the legal trade in generic medicines.
Increase public awareness of counterfeit and falsified medicines. G-8 members will enhance their consumer awareness efforts concerning the dangers of counterfeit, falsified medical products, notably in coordination with international organizations such as the World Health Organization, and make information on rogue online pharmacies Internet sites that sell counterfeit and falsified medical products available to consumers, as appropriate and consistent with each country’s laws and regulations.
Combat Rogue Internet sites selling medical products. G-8 members pledge to exchange available information, as appropriate and in accordance with national law, concerning rogue Internet sites (e.g. pharmacies) that sell counterfeit, falsified medical products, as appropriate and consistent with each country’s laws and regulations.
Share best practices on combating counterfeit and falsified drugs. G-8 members pledge to share available information, as appropriate and in accordance with national law, concerning best practices and counterfeit detection technology, including tracking and tracing systems.
 As described by World Health Organization Fact sheet N°275, January 2010 (http://www.who.int/mediacentre/factsheets/fs275/en/)